| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/2010 | WO2010051335A1 Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor |
| 05/06/2010 | WO2010051310A2 ANTI-TNFα FIBRONECTIN TYPE III DOMAIN BASED SCAFFOLD COMPOSITIONS, METHODS AND USES |
| 05/06/2010 | WO2010051032A1 Method and device for activating stem cells |
| 05/06/2010 | WO2010050980A1 Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers |
| 05/06/2010 | WO2010050903A1 Chimeric flagellins for vaccines |
| 05/06/2010 | WO2010050528A1 Anti-muc1 antibody |
| 05/06/2010 | WO2010050513A1 Polypeptide having function to increase calcium concentration in osteoblast |
| 05/06/2010 | WO2010050508A1 Peptide having anti-diabetic activity and use thereof |
| 05/06/2010 | WO2010050422A1 Agent for treatment of diabetes |
| 05/06/2010 | WO2010050415A1 Cyclic depsipeptide compound and use thereof |
| 05/06/2010 | WO2010050369A1 Prophylactic agent for dental caries |
| 05/06/2010 | WO2010050268A1 Molecular marker for cancer stem cell |
| 05/06/2010 | WO2010050190A1 Molecular marker for cancer stem cell |
| 05/06/2010 | WO2010049933A1 Efficient expression of truncated human rnaset2 in e. coli |
| 05/06/2010 | WO2010049776A1 Drug for treating infections |
| 05/06/2010 | WO2010049590A2 A new pharmaceutical product |
| 05/06/2010 | WO2010049488A1 Treating diabetes melitus using insulin injections with less than daily injection frequency |
| 05/06/2010 | WO2010049438A2 Improved methods of using phosphoantigens for the treatment of diseases |
| 05/06/2010 | WO2010049173A1 Use of inhibitors of host kinases for the treatment of infectious diseases |
| 05/06/2010 | WO2010049103A1 Soluble truncated apom proteins and medical uses thereof |
| 05/06/2010 | WO2010030670A3 Compositions and methods for the prevention of oxidative degradation of proteins |
| 05/06/2010 | WO2010030167A3 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 05/06/2010 | WO2010028651A3 Method of upregulating sorla for the treatment of alzheimer's disease |
| 05/06/2010 | WO2010019103A9 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 05/06/2010 | WO2010017653A8 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 05/06/2010 | WO2010017478A3 Pak1 agonists and methods of use |
| 05/06/2010 | WO2010017224A3 Methods of treating cognitive impairment |
| 05/06/2010 | WO2010016766A3 Antibodies recognizing endogenous human lgr5 and/or lgr6 |
| 05/06/2010 | WO2010010000A3 Screening method, diagnostic method and small nucleic acid for the treatment of cns disorders |
| 05/06/2010 | WO2010005513A3 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 05/06/2010 | WO2010002895A3 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 05/06/2010 | WO2009158284A9 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| 05/06/2010 | WO2009151520A3 Biocompatible and biodegradable elastomeric polymers |
| 05/06/2010 | WO2009149171A4 Fgf21 mutants and uses thereof |
| 05/06/2010 | WO2009144278A3 Conglutin-gamma as medicament and diet supplement |
| 05/06/2010 | WO2009130198A3 Hyperglycosylated human coagulation factor ix |
| 05/06/2010 | WO2009108931A3 Method of treating cancer |
| 05/06/2010 | WO2009108745A8 Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation |
| 05/06/2010 | WO2009013543A3 Targeted binging agents directed to kdr and uses thereof - 035 |
| 05/06/2010 | WO2007081301A3 Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii |
| 05/06/2010 | US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo) |
| 05/06/2010 | US20100114129 Tissue joining devices capable of delivery of bioactive agents and methods of use thereof |
| 05/06/2010 | US20100114074 Sustained delivery of an active agent using an implantable system |
| 05/06/2010 | US20100113861 Metallic nanoparticles with coated shells and applications of same |
| 05/06/2010 | US20100113755 Isolated modified human chorionic gonadotropin proteins |
| 05/06/2010 | US20100113750 Novel scavenger receptor |
| 05/06/2010 | US20100113749 Novel scavenger receptor |
| 05/06/2010 | US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/06/2010 | US20100113605 Methods, compositions and uses thereof |
| 05/06/2010 | US20100113579 Prodrugs of excitatory amino acids |
| 05/06/2010 | US20100113567 Recombinant VSV For The Treatment of Tumor Cells |
| 05/06/2010 | US20100113561 Microrna molecules |
| 05/06/2010 | US20100113487 Pyrimidinone derivatives and methods of use thereof |
| 05/06/2010 | US20100113398 Treatment and/or Prevention of Non-Viral Epithelial Damage |
| 05/06/2010 | US20100113396 Method and Composition for Potentiating an Opiate Analgesic |
| 05/06/2010 | US20100113393 Boronic Acid Salts |
| 05/06/2010 | US20100113370 Methods and compounds for modulating inflammatory processes |
| 05/06/2010 | US20100113369 Means for preventing and treating cellular death and their biological applications |
| 05/06/2010 | US20100113368 Cholesterol lowering protein hydrolysates |
| 05/06/2010 | US20100113367 Peptide-cytotoxic conjugates |
| 05/06/2010 | US20100113366 Use of proline-rich peptide derived from hypothalamus for the manufacture of a medicament for the treatment and/or prophylaxis of cattle leucosis |
| 05/06/2010 | US20100113365 Factor viii polymer conjugates |
| 05/06/2010 | US20100113364 Factor viii polymer conjugates |
| 05/06/2010 | US20100113363 Use of GLP-1 Peptides |
| 05/06/2010 | US20100113362 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis |
| 05/06/2010 | US20100113361 Anti-ige vaccines |
| 05/06/2010 | US20100113360 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 05/06/2010 | US20100113359 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity |
| 05/06/2010 | US20100113358 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
| 05/06/2010 | US20100113357 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 05/06/2010 | US20100113356 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 05/06/2010 | US20100113355 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 05/06/2010 | US20100113354 Therapeutic agent comprising vasohibin |
| 05/06/2010 | US20100113353 Method and composition for inhibiting cardiovascular cell proliferation |
| 05/06/2010 | US20100113352 Retinol formulations and methods for their use |
| 05/06/2010 | US20100113351 Therapeuting Compositions Comprising an RNAi Agent and a Neurotrophic Factor and Methods of Use Thereof |
| 05/06/2010 | US20100113350 Methods and compositions for modulating prostasin |
| 05/06/2010 | US20100113349 Extracellular matrix-binding proteins from staphylococcus aureus |
| 05/06/2010 | US20100113348 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 05/06/2010 | US20100113347 Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| 05/06/2010 | US20100113346 Method of Treating or Preventing Infertility in a Female Mammal and Pharmaceutical Kit for Use in Such Method |
| 05/06/2010 | US20100113345 Preparation of low bleeding anticoagulant fusion protein and its use |
| 05/06/2010 | US20100113344 Method Of Detection Of Nucleic Acids With A Specific Sequence Composition |
| 05/06/2010 | US20100113343 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases |
| 05/06/2010 | US20100113342 Antimicrobial kinocidin compositions and methods of use |
| 05/06/2010 | US20100113341 Methods of using corticotropin-releasing factor for the treatment of cancer |
| 05/06/2010 | US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 05/06/2010 | US20100113339 Serum albumin binding proteins with long half-lives |
| 05/06/2010 | US20100113338 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 05/06/2010 | US20100113337 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 05/06/2010 | US20100113336 Therapeutic agent and method for ovulation disorder caused by luteinized unruptured follicle |
| 05/06/2010 | US20100113335 Compositions and methods for treatement of cancer |
| 05/06/2010 | US20100113334 Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility |
| 05/06/2010 | US20100113333 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 05/06/2010 | US20100113332 Method of treating an inflammatory disease by double stranded ribonucleic acid |
| 05/06/2010 | US20100113331 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors |
| 05/06/2010 | US20100113330 Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof |
| 05/06/2010 | US20100113328 Targeted delivery to legumain-expressing cells |
| 05/06/2010 | US20100113327 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
| 05/06/2010 | US20100113326 Dimeric iap inhibitors |